![](https://ml-eu.globenewswire.com/media/f09f75e6-cbee-41f1-ae9f-29fd0a83134c/small/image1-png.png)
Evexta Bio Reports Progress towards Clinical Development of Rupitasertib in Advanced Breast Cancer
Evexta Bio Reports Progress towards Clinical Development of Rupitasertib in Advanced Breast Cancer Feedback from FDA following Type B meeting enables Evexta Bio to move forward in clinical development of rupitasertib in advanced breast cancer (ABC) Phase 2 …